SEC Form 4 · accession 0001179110-18-008103
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew H Lane
Officer — Executive Vice President
Period of report
Jun 1, 2018
Accepted (ET)
Jun 5, 2018 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par valueF1 | Jun 1, 2018 | A | 3,007 | $0.00 | A | 36,276 | D | |
| Common shares without par valueF2 | Jun 1, 2018 | F | 602 | $61.53 | D | 35,676 | D | |
| Common shares without par valueF3 | holding | — | — | — | 1,239 | I | Profit Sharing Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3.
- F2Includes shares acquired pursuant to a dividend reinvestment feature.
- F3Balance in the Abbott Laboratories Stock Retirement Trust as of June 1, 2018.